IASLC thoracic oncology

Front Cover
 IFC
 IASLC Thoracic Oncology
 IASLC Thoracic Oncology
 Copyright
 Contributors
 Preface
 Contents
 I --
Lung Cancer Control and Epidemiology
 1 --
Classic Epidemiology of Lung Cancer
 DESCRIPTIVE EPIDEMIOLOGY
 RISK FACTORS
 Tobacco Smoking
 Differences in the Effect of Tobacco Smoking According to Histology, Gender, and Race
 Secondhand Tobacco Smoke
 Confounding Effects of Tobacco Smoking
 Interaction Between Tobacco Smoke and Other Lung Carcinogens
 Use of Smokeless Tobacco Products
 Dietary Factors
 Vegetables and Fruits
 Meat and Other Foods
 Coffee and Tea
 Lipids
 Carotenoids. Other MicronutrientsIsothiocyanates
 Alcohol
 Hormones
 Anthropometric Measures
 Infections
 Ionizing Radiation
 Occupational Exposures
 Asbestos
 Metals
 Silica
 Polycyclic Aromatic Hydrocarbons
 Medical Conditions and Treatment
 Indoor Air Pollution
 Outdoor Air Pollution
 Drinking Water Contamination
 CONCLUSION
 KEY REFERENCES
 REFERENCES
 2 --
Tobacco Control and Primary Prevention
 HISTORICAL CONTEXT OF THE TOBACCO EPIDEMIC
 21ST CENTURY TOBACCO-CONTROL MEASURES
 Monitor Tobacco Use and Prevention Policies
 Protect People From Tobacco Smoke
 Offer Help to Quit Tobacco Use. Warn About the Dangers of TobaccoEnforce Bans on Tobacco Advertising, Promotion, and Sponsorship
 Raise Taxes on Tobacco
 Combinations of Measures
 Impact of Tobacco Control on Lung Cancer Mortality
 CONCLUSION
 KEY REFERENCES
 REFERENCES
 3 --
Assessing and Treating Tobacco Use in Lung Cancer Care
 WHY LUNG CANCER SPECIALISTS SHOULD HELP THEIR PATIENTS STOP TOBACCO USE
 Risks of Persistent Smoking and Benefits of Cessation on Lung Cancer Outcomes
 Prevalence of Persistent Smoking Among Patients With Lung Cancer
 FACTORS ASSOCIATED WITH PERSISTENT SMOKING AMONG PATIENTS WITH LUNG CANCER. ASSESSING TOBACCO USE AND INTEGRATING EVIDENCE-BASED TOBACCO TREATMENT IS AN INDICATOR OF HIGH-QUALITY ONCOLOGY CARETREATMENT OF TOBACCO DEPENDENCE IN LUNG CANCER CARE
 Guidelines for Treating Tobacco Use
 Pharmacotherapy
 SPECIAL CONSIDERATIONS IN TREATING TOBACCO DEPENDENCE IN PATIENTS WITH CANCER
 FUTURE DIRECTIONS
 CONCLUSION
 KEY REFERENCES
 REFERENCES
 4 --
Lung Cancer in Never-Smokers: A Different Disease
 EPIDEMIOLOGY OF NONSMOKING-RELATED LUNG CANCER 
 KNOWN OR SUSPECTED ETIOLOGIC FACTORS FOR LUNG CANCER IN NEVER-SMOKERS
 Indoor Air Pollution
 Environmental and Occupational Toxins. Human PapillomavirusCLINICAL-PATHOLOGIC FEATURES OF LUNG CANCER IN NEVER-SMOKERS
 THE GENETICS OF LUNG CANCER
 MOLECULAR CHARACTERISTICS OF NONSMOKING EAST ASIAN INDIVIDUALS WITH LUNG CANCER
 GENOME-WIDE MOLECULAR CHANGES
 PRENEOPLASTIC CHANGES
 DNA METHYLATION
 CONCLUSION
 KEY REFERENCES
 REFERENCES
 5 --
Gender-Related Differences in Lung Cancer
 EPIDEMIOLOGY
 United States
 Europe
 Asia
 SUSCEPTIBILITY
 Never-Smokers
 Smokers
 GENETIC FACTORS
 FAMILY HISTORY
 VIRAL FACTORS
 ENVIRONMENTAL EXPOSURES, DIET, AND PREEXISTING LUNG DISEASE
 Environmental Exposures
 Diet
 Preexisting Lung Disease.